When will Compass Pathways submit a NDA for COMP360 psilocybin?
14.0 pt (24h)Health & MedicineOne-OffScienzaBusiness & Corporate21g
KalshiVerifica disponibilitàKYC richiesto2% di commissioneDati di risoluzione verificatiDiscretamente calibratoProbabilità implicita attuale
before April 2027 83%In testa tra 6 esiti
Qualità del mercato
42 / 100
Bassa qualitàVolume 24h
997,3 €
Liquidità
8,7K €
Liquidità mediaSpread
20.0 pt
Spread ampioDati di mercato
Aggiornato 5 minuti fa
24 mar 26, 14:00 UTC1 ott 26, 14:00 UTC
Trend
Mercati Correlati
Domande correlate per il contesto, non un confronto tra contratti equivalenti.
When will the FDA approve Compass Pathways' COMP360 Psilocybin?
Kalshi[ACX 2026] Will the FDA approve a psilocybin treatment during 2026?
Manifold MarketsWill psilocybin remain Schedule I through the end of 2027?
Manifold MarketsWill the FDA approve a psilocybin treatment during 2026?
FutuurWhich fast food chain in the USA will offer a lab-grown / cultivated meat product first?
Manifold MarketsWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
KalshiRegole
If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Sep 1, 2026, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Oct 1, 2026, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Nov 1, 2026, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Dec 1, 2026, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Jan 1, 2027, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Apr 1, 2027, then the market resolves to Yes.
Mercati aperti
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No-0.2pt97%
- Yes+0.2pt3%
- Volume totale
- 15,6 Mln €
- Volume 24h
- 30,4K €
POLYMARKETEbola pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Volume totale
- 652,8K €
- Volume 24h
- 3,5K €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No97%
- Yes-0.7pt3%
- Volume totale
- 1,6 Mln €
- Volume 24h
- 2,9K €
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 4000+1.0pt97%
- Above 600059%
+2 altri esiti
- Volume totale
- 865,3K €
- Volume 24h
- 2,7K €
POLYMARKETNew pandemic in 2026?
- No+1.0pt94.1%
- Yes-1.0pt5.9%
- Volume totale
- 915,3K €
- Volume 24h
- 1,4K €
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+1.0pt65%
- September41%
- June28%
- Volume totale
- 84K €
- When will the FDA approve Intellia Therapeutics' lonvo-z?
- Will 3 mg THC beverages be federally legal to sell?
- Cyclosporiasis cases reported in the US in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- What will the average number of measles cases be during Trump's term?
- Will the FDA approve CagriSema?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- Measles cases in U.S. in 2026?
- FDA decision: Ifinatamab Deruxtecan by Daiichi Sankyo (in 2026)
- FDA decision: Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences (in 2026)
- Heidi Overton confirmed as FDA Commissioner by which date?
Domande frequenti
- Quali sono le probabilità attuali per When will Compass Pathways submit a NDA for COMP360 psilocybin??
- Kalshi quota before April 2027 al 83% al 9 settembre 2026.
- Quando si risolve When will Compass Pathways submit a NDA for COMP360 psilocybin??
- When will Compass Pathways submit a NDA for COMP360 psilocybin? dovrebbe risolversi il 1 ottobre 2026.
- Come viene liquidato When will Compass Pathways submit a NDA for COMP360 psilocybin??
- Kalshi liquida questo mercato come segue: If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Sep 1, 2026, then the market resolves to Yes.